This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kouatli, A. A. Articles by Mahony, L. Search for Related Content PubMed PubMed Citation Articles by Kouatli, A. A. Articles by Mahony, L. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ENALAPRIL MALEATE

(Circulation. 1997;96:1507-1512.)
© 1997 American Heart Association, Inc.

Articles

Enalapril Does Not Enhance Exercise Capacity in Patients After Fontan Procedure

Amjad A. Kouatli, MD; Jorge A. Garcia, MD; Thomas M. Zellers, MD; Ellen M. Weinstein, MD; ; Lynn Mahony, MD

From the Department of Pediatrics, University of Texas Southwestern Medical Center at Dallas.

Background Angiotensin-converting enzyme inhibitors improve exercise capacity in adults with congestive heart failure by decreasing systemic vascular resistance and improving ventricular diastolic function. Patients who have undergone the Fontan procedure have decreased cardiac output, increased systemic vascular resistance, abnormal diastolic function, and decreased exercise capacity compared with normal people.

Methods and Results To test the hypothesis that afterload reduction therapy alters hemodynamic variables and augments exercise capacity in patients after a Fontan procedure, we compared the results of graded exercise with maximal effort from 18 subjects (14.5±6.2 years of age, 4 to 19 years after Fontan procedure) in a randomized, double-blind, placebo-controlled crossover trial using enalapril (0.2 to 0.3 mg · kg^-1 · d^-1, maximum 15 mg). Each treatment was administered for 10 weeks. Diastolic filling patterns at rest were assessed by Doppler determination of the systemic atrioventricular valve flow velocity at the conclusion of each therapy. No difference was detected in resting heart rate, blood pressure, or cardiac index. Diastolic filling patterns were also similar. Exercise duration was not different (6.4±2.6 [enalapril] versus 6.7±2.6 minutes [placebo]). The mean percent increase in cardiac index from rest to maximum exercise was slightly but significantly decreased in subjects after 10 weeks of enalapril therapy (102±34% [enalapril] versus 125±34% [placebo]; P<.02). At maximal exercise, cardiac index (3.5±0.9 [enalapril] versus 3.8±0.9 L · min^-1 · m² [placebo]), oxygen consumption (18.3±9 [enalapril] versus 20.5±7 mL · min^-1 · kg^-1 [placebo]), minute ventilation (57.5±17 [enalapril] versus 55.4±19 L/min [placebo]), and total work (247±181 [enalapril] versus 261±197 W [placebo]) were not different.

Conclusions We conclude that enalapril administration for 10 weeks does not alter abnormal systemic vascular resistance, resting cardiac index, diastolic function, or exercise capacity in patients who have undergone a Fontan procedure.

Key Words: heart defects, congenital • Fontan procedure • angiotensin • enzymes • exercise

This article has been cited by other articles:

				R. E. Shaddy, M. M. Boucek, D. T. Hsu, R. J. Boucek, C. E. Canter, L. Mahony, R. D. Ross, E. Pahl, E. D. Blume, D. A. Dodd, et al. Carvedilol for Children and Adolescents With Heart Failure: A Randomized Controlled Trial JAMA, September 12, 2007; 298(10): 1171 - 1179. [Abstract] [Full Text] [PDF]

				P. Khairy, N. Poirier, and L.-A. Mercier Univentricular Heart Circulation, February 13, 2007; 115(6): 800 - 812. [Abstract] [Full Text] [PDF]

				D. Rosenthal and D. Bernstein Pediatric Mechanical Circulatory Support: Challenges and Opportunities Circulation, May 16, 2006; 113(19): 2266 - 2268. [Full Text] [PDF]

				S. Khambadkone, J. Li, M.R. de Leval, S. Cullen, J.E. Deanfield, and A.N. Redington Basal Pulmonary Vascular Resistance and Nitric Oxide Responsiveness Late After Fontan-Type Operation Circulation, July 1, 2003; 107(25): 3204 - 3208. [Abstract] [Full Text] [PDF]

				H. Senzaki, S. Masutani, J. Kobayashi, T. Kobayashi, N. Sasaki, H. Asano, S. Kyo, Y. Yokote, and A. Ishizawa Ventricular Afterload and Ventricular Work in Fontan Circulation: Comparison With Normal Two-Ventricle Circulation and Single-Ventricle Circulation With Blalock-Taussig Shunts Circulation, June 18, 2002; 105(24): 2885 - 2892. [Abstract] [Full Text] [PDF]

				H. Ohuchi, S. Hasegawa, K. Yasuda, O. Yamada, Y. Ono, and S. Echigo Severely Impaired Cardiac Autonomic Nervous Activity After the Fontan Operation Circulation, September 25, 2001; 104(13): 1513 - 1518. [Abstract] [Full Text] [PDF]

				Y F Cheung, D J Penny, and A N Redington Serial assessment of left ventricular diastolic function after Fontan procedure Heart, April 1, 2000; 83(4): 420 - 424. [Abstract] [Full Text]

				V E Hjortdal, E V Stenbøg, H B Ravn, K Emmertsen, K T Jensen, E B Pedersen, K H Olsen, O K Hansen, and K E Sørensen Neurohormonal activation late after cavopulmonary connection Heart, April 1, 2000; 83(4): 439 - 443. [Abstract] [Full Text]